Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Baptist Health Herbert Wertheim Cancer Institute Treats Its 100th CAR T-Cell Therapy Patient
Baptist Health Herbert Wertheim Cancer Institute has reached a significant milestone in cancer care: the treatment of its 100th patient with CAR T-cell therapy.
Baptist Health Herbert Wertheim Cancer Institute has treated its 100th patient with CAR T-cell therapy.
2
CAR T-cell therapy modifies a patient’s T cells to recognize cancer cells, expands them in a laboratory, and infuses them back after preparatory chemotherapy.
3
The Institute’s CAR T-cell program operates under the leadership of Guenther Koehne, MD, PhD, and relies on collaboration across clinical and support teams.
4
The Institute has onsite cell processing in a certified Good Manufacturing Practice laboratory, and its Blood and Marrow Stem Cell Transplant Program is FACT accredited.
5
The Institute’s program is part of the Memorial Sloan Kettering Cancer Alliance and provides dedicated inpatient bone marrow and immunotherapy care at Hope Tower.
Antonio Gioradano, MD, presents efficacy and safety of atirmociclib + fulvestrant in HR+/HER2- advanced breast cancer after progressing on prior CDK4/6 inhibitor - data from phase 2 FOURLIGHT-1 study.